繁體版 / 簡體版
 
NEWS ROOM
/ NEWS ROOM
2018-06-07
Fountain Biopharma Inc. Granted Singapore Patent for Method of Producing Mono-glycosylated Antibody

Fountain Biopharma Inc. announces a method of producing mono-glycosylated antibody was received patent from Singapore Intellectual Property Office (IPOS).

Title of the patent is “METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION”, patent no.11201607759R.

The method optimizes the glycosylation of the antibody through cell engineering technology will effectively reduce the cost of production of glycan-modified antibody which will increase the profit.

Fountain Biopharma Inc. Granted USA Patent for Method of Producing Mono-glycosylated Antibody in 2017.


模拟人生4 俱乐部赚钱 pk10计划软件手机版 财神爷pk10软件怎么样 广西快3预测分析 河北11选5模拟选号 秒速快三投注技巧 广西十一选五走势图下载 股票该怎么玩 北京快三下载 陕西快乐十分开奖时间 安徽快3和值遗漏